G1 Therapeutics, Inc.
GTHXDelisted Sep 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001560241
G1 Therapeutics, Inc. was delisted on Sep 18, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 88 institutions reported holding it in 13F filings for Q2 2024, worth $45.5M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in G1 Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- −18 vs. Q4 2022
- Shares held
- 19.2M
- −3.89M (−16.9%) vs. Q4 2022
- Total value
- $51.5M
- −$73.6M (−58.9%) vs. Q4 2022
- New holders
- 11
- 31 more added
- Sold out
- 29
- 37 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GTHX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 88 | $45.5M |
| Q1 2024 | 86 | $61.6M |
| Q4 2023 | 87 | $38.5M |
| Q3 2023 | 72 | $15.8M |
| Q2 2023 | 80 | $38.6M |
| Q1 2023 | 97 | $51.5M |
| Q4 2022 | 116 | $125.1M |
| Q3 2022 | 104 | $287.5M |
| Q2 2022 | 98 | $98.2M |
| Q1 2022 | 115 | $183.8M |
| Q4 2021 | 108 | $270.6M |
| Q3 2021 | 115 | $357.8M |
| Q2 2021 | 114 | $541.8M |
| Q1 2021 | 123 | $582.2M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding G1 Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Norges Bank | 0 | $0 | 0.00% | −225,700−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −150,930−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −137,746−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −115,751−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −109,339−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −77,450−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −46,551−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −44,603−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −42,951−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −39,465−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −30,475−100.0% | Sold out |
| Cornerstone National Bank & Trust Co | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −24,085−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −23,542−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −18,093−100.0% | Sold out |
| PVG Asset Management Corp | 0 | $0 | 0.00% | −15,585−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −13,856−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −13,241−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −12,509−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −10,012−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −9,496−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −2,086−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −712−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −130−100.0% | Sold out |
| Trustcore Financial Services, LLC | – | – | – | – | Not filed |